The University of Southampton
University of Southampton Institutional Repository

A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes

A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes
A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes
0903-1936
Abdel-Aziz, Mahmoud I
a00deb2f-ba5f-4298-9a80-03a98c6b0b00
Vijverberg, Susanne J H
d8b28889-f3e2-4eb7-afdb-45d6012ec597
Neerincx, Anne H
7cae6dae-f4c4-45f0-9d21-a4640dd6b48f
Brinkman, Paul
62ed409d-297d-465a-b165-6c5c05ea04b2
Wagener, Ariane H
8b3a8d48-8572-4392-8a3a-8dd1dfecb476
Riley, John H
66454d3a-c673-4b84-b66b-40fab791d61d
Sousa, Ana R
f91bc470-6709-4a15-a5de-729f2771adba
Bates, Stewart
1be75e2f-b076-459a-a55b-9377ce2aa0e3
Wagers, Scott S
4210bc1c-ebd9-41a2-be31-b12bfa2b8c3c
De Meulder, Bertrand
2eb16e68-bc1a-4e71-bc76-a6ebcb079cbd
Auffray, Charles
16fdf8f6-e7bc-4559-b6b6-d425160867c6
Wheelock, Åsa M
0c935319-f85a-4c3e-b7c8-218727bdeb01
Bansal, Aruna T
35fbf858-fffc-474a-b176-28ed5a20b9c8
Caruso, Massimo
d6a59da8-4f93-4926-93a6-e7c3b90b480f
Chanez, Pascal
695ba8e7-e6b7-49db-a88f-e5f5a366b869
Uddin, Mohib
4abfc197-403a-44ec-9921-2ddd9d304e3b
Corfield, Julie
662175c2-d799-4c6b-b2e7-feea13a59915
Horvath, Ildiko
57682232-afd3-47ac-8725-ba6e92dc06ae
Krug, Norbert
68944b71-ec40-4d74-9f8f-773ea8599b0a
Musial, Jacek
4cc2db1c-776b-4f5a-8ec9-f8362ef9a6b9
Sun, Kai
03d1f059-1a17-4867-9e57-903adcf9cd96
Shaw, Dominick E
83e98e0a-fd2d-4c44-9249-6ac3ebd9614f
Sandström, Thomas
77a4c11d-a84f-4a52-9bfe-4ec83f62363a
Montuschi, Paolo
10568e50-5a5f-47b3-9ac8-6a630c30882c
Fowler, Stephen J
7a077c2e-22e7-4a0c-b781-eec92fb931c8
Lutter, René
46082b29-b6a0-437e-8689-1f39e439c285
Djukanovic, Ratko
d9a45ee7-6a80-4d84-a0ed-10962660a98d
Howarth, Peter
ff19c8c4-86b0-4a88-8f76-b3d87f142a21
Skipp, Paul
1ba7dcf6-9fe7-4b5c-a9d0-e32ed7f42aa5
Sanak, Marek
a4cb9b3b-a343-427a-877a-e00066604bb0
Adcock, Ian M
427153bc-3b8b-4066-aa4e-5bc41a6c36dd
Chung, Kian Fan
dc062fa0-b6c4-4b03-a0c2-917904e0ea2a
Sterk, Peter J
cffc8681-7dc8-4328-ac93-4d5d5c4319b9
Kraneveld, Aletta D
dad3bdf6-efb7-4548-8b0b-b097c710465e
Maitland-van der Zee, Anke H
9e203186-acd6-480c-beb6-fe30ed0353d3
U-BIOPRED Study Group
Abdel-Aziz, Mahmoud I
a00deb2f-ba5f-4298-9a80-03a98c6b0b00
Vijverberg, Susanne J H
d8b28889-f3e2-4eb7-afdb-45d6012ec597
Neerincx, Anne H
7cae6dae-f4c4-45f0-9d21-a4640dd6b48f
Brinkman, Paul
62ed409d-297d-465a-b165-6c5c05ea04b2
Wagener, Ariane H
8b3a8d48-8572-4392-8a3a-8dd1dfecb476
Riley, John H
66454d3a-c673-4b84-b66b-40fab791d61d
Sousa, Ana R
f91bc470-6709-4a15-a5de-729f2771adba
Bates, Stewart
1be75e2f-b076-459a-a55b-9377ce2aa0e3
Wagers, Scott S
4210bc1c-ebd9-41a2-be31-b12bfa2b8c3c
De Meulder, Bertrand
2eb16e68-bc1a-4e71-bc76-a6ebcb079cbd
Auffray, Charles
16fdf8f6-e7bc-4559-b6b6-d425160867c6
Wheelock, Åsa M
0c935319-f85a-4c3e-b7c8-218727bdeb01
Bansal, Aruna T
35fbf858-fffc-474a-b176-28ed5a20b9c8
Caruso, Massimo
d6a59da8-4f93-4926-93a6-e7c3b90b480f
Chanez, Pascal
695ba8e7-e6b7-49db-a88f-e5f5a366b869
Uddin, Mohib
4abfc197-403a-44ec-9921-2ddd9d304e3b
Corfield, Julie
662175c2-d799-4c6b-b2e7-feea13a59915
Horvath, Ildiko
57682232-afd3-47ac-8725-ba6e92dc06ae
Krug, Norbert
68944b71-ec40-4d74-9f8f-773ea8599b0a
Musial, Jacek
4cc2db1c-776b-4f5a-8ec9-f8362ef9a6b9
Sun, Kai
03d1f059-1a17-4867-9e57-903adcf9cd96
Shaw, Dominick E
83e98e0a-fd2d-4c44-9249-6ac3ebd9614f
Sandström, Thomas
77a4c11d-a84f-4a52-9bfe-4ec83f62363a
Montuschi, Paolo
10568e50-5a5f-47b3-9ac8-6a630c30882c
Fowler, Stephen J
7a077c2e-22e7-4a0c-b781-eec92fb931c8
Lutter, René
46082b29-b6a0-437e-8689-1f39e439c285
Djukanovic, Ratko
d9a45ee7-6a80-4d84-a0ed-10962660a98d
Howarth, Peter
ff19c8c4-86b0-4a88-8f76-b3d87f142a21
Skipp, Paul
1ba7dcf6-9fe7-4b5c-a9d0-e32ed7f42aa5
Sanak, Marek
a4cb9b3b-a343-427a-877a-e00066604bb0
Adcock, Ian M
427153bc-3b8b-4066-aa4e-5bc41a6c36dd
Chung, Kian Fan
dc062fa0-b6c4-4b03-a0c2-917904e0ea2a
Sterk, Peter J
cffc8681-7dc8-4328-ac93-4d5d5c4319b9
Kraneveld, Aletta D
dad3bdf6-efb7-4548-8b0b-b097c710465e
Maitland-van der Zee, Anke H
9e203186-acd6-480c-beb6-fe30ed0353d3

Abdel-Aziz, Mahmoud I, Vijverberg, Susanne J H, Neerincx, Anne H, Brinkman, Paul, Wagener, Ariane H and Riley, John H , U-BIOPRED Study Group (2022) A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes. The European respiratory journal, 59 (1), [2102603]. (doi:10.1183/13993003.02603-2021).

Record type: Article
Text
Research letter_30_09_2021 - Author's Original
Download (955kB)

More information

Accepted/In Press date: 11 October 2021
e-pub ahead of print date: 13 January 2022
Published date: 13 January 2022
Additional Information: Funding Information: Conflicts of interest: M.I. Abdel-Aziz, S.J.H. Vijverberg, A.H. Neerincx, P. Brinkman, A.H. Wagener, A.R. Sousa, Å.M. Wheelock, AT. Bansal, M. Caruso, J. Corfield, N. Krug, J. Musial, K. Sun, D.E. Shaw, P. Montuschi, R. Lutter, P. Howarth, M. Sanak, I.M. Adcock, P. Chanez and AD. Kraneveld have no conflicts of interest to disclose. J.H. Riley was an employee and a shareholder of GlaxoSmithKline. S. Bates is an employee of Johnson & Johnson and a former employee of GlaxoSmithKline, and holds stock in both companies. S.S. Wagers reports consulting fees from Kings College Hospital NHS Foundation Trust, Academic Medical Research, Aladdin Healthcare Technologies Ltd, AMC Medical Research BV, AMC Medical Research BV P402, Asthma UK, AstraZeneca AB, Athens Medical School, Autobedrijf Verfaillie V-CO BVBA, Boehringer Ingelheim International GmbH, Breathomix BV, Chiesi Farmaceutici S.p.A., CHU de Toulouse, CIRO, Consorcio Centro de Investigación Biomédica en Red, Dawi Iman Automobile, DS Biologicls Ltd, École Polytechnique Fédérale de Lausanne, European Federation of Allergy, European Respiratory Society, European Society for Swallowing Disorders, F. Hoffmann-La Roche AG, FISEVI, Fluidic Analytics Ltd, Foundation for Research and Technology Hellas, Fraunhofer IGB, Fraunhofer ITEM, Fraunhofer-Institut für Produktionstechnologie IPT, GlaxoSmithKline Research & Dev Ltd, Gossamer Bio, Inc, Holland & Knight, Imperial College, Institute for Computer Science and Control, Karolinska Institutet Fakturor, KU Leuven, Longfonds, Maastricht University, MedImmune LLC, Merck Sharp & Dohme Corp., National Heart & Lung Institute, Ninja Hoen, Novartis Pharma AG, OncoRadiomics S.A., Owlstone Medical Limited, PExA AB, Pulmonary Fibrosis Foundation, RISE Research Institutes of Sweden AB, Sanofi US Services Inc., TEVA Branded Pharmaceutical Products R&D Inc., The North West Lung Centre Charity, Three Lakes Foundation Trust, TopMD Precision Medicine Ltd, UCB Biopharma S.P.R.L., UCB Biosciences GmbH, UGent, Umeå University, Univ. Hospital Southampton NHS Foundation Trust, Università Campus Bio-Medico di Roma, Universita Cattolica Del Sacro Cuore, Universität Ulm, Universitätsklinikum Würzburg, University College London, University Hospital Southampton, University of Bern, University of Edinburgh, University of Hull, University of Leicester, University of Loughborough, University of Luxembourg, University of Manchester, University of Nottingham, VITO NV, Vlaams Brabant, Dienst Europa, Kings College Hospital NHS Foundation Trust, and Academic Medical Research paid to his company (BioSci Consulting); outside the submitted work. B. De Meulder and C. Auffray have received grants from Innovative Medicines Initiative (IMI U-BIOPRED grant number 115010 and IMI eTRIKS grant number 115446), during the conduct of the study. M. Uddin is an employee of AstraZeneca and holds shares in the company. I. Horvath has received personal honoraria for lectures from AstraZeneca, Chiesi, GSK, Novartis and MSD, and had unpaid leadership or fiduciary roles in European Respiratory Society, Hungarian Respiratory Society, and Hungarian Association of Medical Societies. T. Sandström has received fees from lecturing for Boehringer Ingelheim with payments to clinic/ institution. S.J. Fowler has received honoraria for lectures from AstraZeneca, Novartis, Teva, Boehringer Ingelheim and Chiesi, and has received support to attend ERS and BTS meetings from AstraZeneca and Chiesi, and participated in the advisory board of Chiesi. R. Djukanovic is a co-founder of and has stocks with Synairgen, a University of Southampton spin out company, which is funding a phase 3 trial of nebulised interferon beta for treatment of hospitalised COVID-19 patients and a community based study of PCR positive individuals to see if treatment can improve clinical outcomes, and is a member (without receiving funding) of the Urgent Public Health (UPH) panel that approves studies under a priority badge, and has received fees for consultancy services from TEVA Pharmaceuticals, Sanofi, Boehringer and Novartis, and has received grants (paid to his institution) from IMI funded EU project, UBIOPRED, MRC funded project on COPD: COPD-MAP and Novartis to Study of mechanisms of action of Omalizumab, and has received fees for lectures on mechanisms of action of Xolair for Novartis and a lecture in symposium on mechanisms of asthma for Teva. P. Skipp is a shareholder in TopMD Precision Medicine. K.F. Chung reports funding during the conduct of the study paid to his institution from the Innovative Medicines Initiative (IMI) Joint Undertaking under grant agreement number 115010. P.J. Sterk reports funding during the conduct of the study paid to his institution from Innovative Medicines Initiative (IMI), which is public-private funding provided by the EU and the European Federation of Pharmaceutical Industries and Associations (EFPIA), and is a scientific adviser and has an officially non-substantial interest in the start-up company Breathomix BV, The Netherlands; outside the submitted work. A.H. Maitland-van der Zee has received grants from Health Holland and she is the PI of a P4O2 (Precision Medicine for more Oxygen) public private partnership sponsored by Health Holland involving many private partners that contribute in cash and/or in kind (Boehringer Ingelheim, Breathomix, Fluidda, Ortec Logiqcare, Philips, Quantib-U, Smartfish, SODAQ, Thirona, TopMD and Novartis), received unrestricted research grants from GSK, Boehringer Ingelheim and Vertex, received consulting fees paid to her institution from Boehringer Ingelheim and AstraZeneca, and received honoraria for lectures paid to her institution from GlaxoSmithKline; outside the submitted work. Funding Information: Support statement: U-BIOPRED has received funding from the Innovative Medicines Initiative (IMI) Joint Undertaking under grant agreement no. 115010, resources of which are composed of financial contributions from the European Union’s Seventh Framework Programme (FP7/2007–2013) and European Federation of Pharmaceutical Industries and Associations (EFPIA) companies’ in-kind contributions (www.imi.europa.eu). The researcher M.I. Abdel-Aziz is funded by a full scholarship from the Ministry of Higher Education of the Arab Republic of Egypt. Funding information for this article has been deposited with the Crossref Funder Registry.

Identifiers

Local EPrints ID: 456845
URI: http://eprints.soton.ac.uk/id/eprint/456845
ISSN: 0903-1936
PURE UUID: b5a0fa77-1037-4482-8e9c-f6c4a1b601ca
ORCID for Ratko Djukanovic: ORCID iD orcid.org/0000-0001-6039-5612
ORCID for Paul Skipp: ORCID iD orcid.org/0000-0002-2995-2959

Catalogue record

Date deposited: 12 May 2022 16:54
Last modified: 03 May 2024 04:01

Export record

Altmetrics

Contributors

Author: Mahmoud I Abdel-Aziz
Author: Susanne J H Vijverberg
Author: Anne H Neerincx
Author: Paul Brinkman
Author: Ariane H Wagener
Author: John H Riley
Author: Ana R Sousa
Author: Stewart Bates
Author: Scott S Wagers
Author: Bertrand De Meulder
Author: Charles Auffray
Author: Åsa M Wheelock
Author: Aruna T Bansal
Author: Massimo Caruso
Author: Pascal Chanez
Author: Mohib Uddin
Author: Julie Corfield
Author: Ildiko Horvath
Author: Norbert Krug
Author: Jacek Musial
Author: Kai Sun
Author: Dominick E Shaw
Author: Thomas Sandström
Author: Paolo Montuschi
Author: Stephen J Fowler
Author: René Lutter
Author: Peter Howarth
Author: Paul Skipp ORCID iD
Author: Marek Sanak
Author: Ian M Adcock
Author: Kian Fan Chung
Author: Peter J Sterk
Author: Aletta D Kraneveld
Author: Anke H Maitland-van der Zee
Corporate Author: U-BIOPRED Study Group

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×